Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALXN2050 Drug Interactions with Fluconazole and Rifampin in Healthy Adults
NCT04933682Phase 1Completed
- Sponsor
- Alexion Pharmaceuticals
- Start
- Jun 2021
- Primary completion
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of vemircopan (2 arms), sponsored by Alexion Pharmaceuticals. Primary endpoints: Area Under The Concentration-time Curve From Time 0 To Infinity, Maximum Observed Concentration and 2 more. Started Jun 2021; status: completed.
02
Drugs
vemircopan
Beyond the preview
Go deeper on NCT04933682.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04933682.